Introduction {#S1}
============

Prolyl isomerases (PPIases) catalyze the *cis-trans* isomerization of the peptidy prolyl (X-Pro) bonds. There are three distinct families of PPIases: cyclophilins (CyPs), FK506-binding proteins (FKBPs), and parvulins ([@B163]). Pin1 belongs to the parvulin family and is comprised of an N-terminal WW domain serving as a phosphoprotein-binding module and a C-terminal catalytic domain that is distinct from other conventional PPIases ([@B163]). Because of its unique WW and PPIase domains, Pin1 specifically isomerizes the pSer/Thr-Pro motif and regulates the functions of a defined group of phosphoproteins by altering their conformations ([@B75]). Pin1-mediated post-phosphorylation regulation has profound effects on multiple cellular and biological processes, including cell cycle, cell differentiation and death, and metabolic and immune response ([@B75]; [@B163]). Aberrant expression of Pin1 has been identified to be associated with many diseases, especially in cancer and neurodegenerative disorders, such as Parkinson's disease (PD) and Alzheimer's disease (AD) ([@B75]; [@B163]). While Pin1 is highly expressed in the majority of cancers and promotes cancer progression, its expression is down-regulated in neurodegenerative diseases ([@B75]; [@B163]), highlighting the diverse regulatory functions of Pin1 in physiology and diseases.

The temporal and spatial eukaryotic gene expression is a highly orchestrated molecular event that is regulated at multiple levels and is responsible for the distinct cellular responses and functions. The multi-level regulation includes the signal-dependent activation of tissue-specific transcription factors, the remodeling of chromatin on promoters and enhancers, the pausing and release of RNAPII, the post-transcriptional processing of mRNA, and the translational regulation ([@B133]; [@B26]; [@B49]). Post-translational modifications, especially phosphorylation, play important roles in the multi-level regulation of gene expression ([@B104]). Many transcription factors and transcription related proteins undergo phosphorylation and activate gene expression in response to intra- and extracellular stimuli ([@B54]). The reversible phosphorylation on serine or threonine residues preceding a proline (pSer/Thr-Pro) has emerged as a pivotal switch for controlling the activities of participating transcription components in gene expression ([@B124]; [@B46]). Pin1's ability to regulate many cellular processes might rely on its ability to regulate the expression of various genes by binding to the phosphorylated transcription regulators. More than 40 different kinds of transcription related proteins, including transcription activators and general transcription machinery components, have been identified to be Pin1 substrates ([Table 1](#T1){ref-type="table"}). Pin1 binds to the pSer/Thr-Pro motifs of these proteins and regulates the gene transcription by altering the stability, subcellular localization, protein-protein interactions, and protein-DNA/RNA interaction of these factors ([@B150]). In this review, we summarize how Pin1 controls the activity of these transcription regulators for the spatiotemporal expression of genes involved in cell cycle, cell proliferation and growth, metabolism and inflammation, thus contributing to the diverse functions of Pin1 in physiology and disease.

###### 

List of Pin1 substrates in transcription regulation.

  Substrates                                                  Motif                    Regulation by Pin1                                               Cellular consequence of Pin1 interaction                        Evidence of isomerization   References
  ----------------------------------------------------------- ------------------------ ---------------------------------------------------------------- --------------------------------------------------------------- --------------------------- ---------------------------------
  **Transcription factors**                                                                                                                                                                                                                         
  **(1) Nucleocytoplasmic shuttling**                                                                                                                                                                                                               
  RelA                                                        T254                     Increased nuclear accumulation and stability                     Cell survival, proliferation and inflammation                   Yes                         [@B119]; [@B3]; [@B32]; [@B130]
  β-catenin                                                   S246                     Increased nuclear accumulation and stability                     Cancer cell proliferation, osteogenesis                         Yes                         [@B118]; [@B92]
  Fox04                                                       N/A                      Deubiquitylation and decreased nuclear accumulation              Cell cycle and cancer cell proliferation                        Yes                         [@B12]
  NFAT                                                        N/A                      Decreased nuclear accumulation                                   T cell activation                                               N/A                         [@B76]
  **(2) Protein stability**                                                                                                                                                                                                                         
  p53                                                         S33, S46, T81, S315      Increased stability and transactivation                          DNA damage response, cancer cell cycle arrest and apoptosis     Yes                         [@B146]; [@B157]; [@B162]
  p63                                                         T538                     Increased or decreased stability                                 Cancer and limb development                                     N/A                         [@B70]; [@B114]
  p73                                                         S412, T442, T482         Increased stability and transactivation                          Apoptosis                                                       Yes                         [@B84]
  c-Jun                                                       S63, S73                 Increased stability                                              Ras and JNK signaling                                           Yes                         [@B147]; [@B108]
  Naong                                                       S52, S65, S71, T287      Increased stability                                              Stem cell pluripotency                                          Yes                         [@B88]
  Oct4                                                        S12                      Increased stability                                              Stem cell pluripotency                                          Yes                         [@B101]
  FoxMl                                                       S331, S704               Increase stability                                               Drug resistance                                                 N/A                         [@B63]; [@B142]
  Osterix                                                     S76, S80                 Increase stability and transactivation                           Osteogenic differentiation                                      Yes                         [@B57]
  ATF1                                                        T184                     Increase stability and transactivation                           NPC tumorigenesis                                               N/A                         [@B53]
  TR3                                                         S95, S140, S431          Increase stability and transactivation                           Mitogenesis                                                     Yes                         [@B17]
  Runx2                                                       T408, T449, S472, S510   Increase sub-nuclear area accumulation and stability             Skeletal development, Osteoblast differentiation.               Yes                         [@B66]; [@B156]
  Runx3                                                       T209, T212, T231, S214   Degradation, suppresses transactivation                          Breast cancer cell proliferation                                Yes                         [@B100]
  Smad3                                                       T179, S204, S208, S213   Decreased stability                                              Cell migration and invasion                                     Yes                         [@B93]
  IRF3                                                        S339                     Decreased stability                                              Antiviral responses                                             Yes                         [@B120]
  RAR                                                         S77                      Decreased stability                                              Cancer cell proliferation                                       Yes                         [@B40]
  MEF2C                                                       S98, S110                Decreased stability                                              Muscle terminal differentiation                                 Yes                         [@B83]
  Fox03                                                       N/A                      Decreased stability                                              Drug resistance                                                 No                          [@B128]
  **(3) DNA binding activity and transcriptional activity**                                                                                                                                                                                         
  c-Myc                                                       T58, S62                 Decreased stability, increased DNA binding                       Cancer cell proliferation                                       Yes                         [@B154]; [@B33]
  ERα                                                         S118, S294               Increased dimerization, stability and transactivation activity   Cancer cell proliferation                                       Yes                         [@B112]
  HIFIα                                                       S641, S643               Increase stability and transactivation                           Angiogenesis                                                    Yes                         [@B56]; [@B44]
  SP1                                                         T739                     Increased stability, decreased DNA binding                       Cell cycle progression                                          Yes                         [@B153]
  c-Fos                                                       T232, T325, T331         Increased interaction with other transcription factors           Mitogen response                                                Yes                         [@B86]
  GR                                                          S203, S211               Increased transactivation                                        Inflammatory response                                           Yes                         [@B106]
  PPARγ                                                       S273                     Increased stability and transactivation                          Adipogenesis                                                    N/A                         [@B37]; [@B45]
  Nur77                                                       S152                     Increased DNA binding and transactivation                        Vascular disease and metabolism                                 No                          [@B139]
  Stat3                                                       S272                     Increased DNA binding and transactivation                        EMT and type 2 diabetes                                         No                          [@B79]; [@B81]; [@B91]
  **Transcription cofactors**                                                                                                                                                                                                                       
  SRC-3                                                       multiple sites           Increased interaction with p300 and degradation                  Brease cancer cell proliferation                                Yes                         [@B155]
  Notch1                                                      S2122, T2133, S2137      Enhanced Notch1 cleavage and transcriptional activity            Notch signaling                                                 Yes                         [@B117]
  SMRT                                                        S1241, S1445, S1469      Decreased stability                                              Cancer cell proliferation and response to tamoxifen             Yes                         [@B136]
  CRTC2                                                       S136                     Decreased nuclear accumulation                                   Glucose metabolism                                              N/A                         [@B97]
  PRDM16                                                      N/A                      Decreased stability                                              Thermogenesis                                                   N/A                         [@B21]
  **RNA polymerase**                                                                                                                                                                                                                                
  Rpbl                                                        S2, S5 of CTD            Altered phosphorylation of CTD                                   Transcription                                                   Yes                         [@B149]; [@B160]
  **Histone**                                                                                                                                                                                                                                       
  Histone HI                                                  multiple sites           Increased dephosphorylation and binding to chromatin             Transcription                                                   Yes                         [@B109]
  **Transcription elongation regulators**                                                                                                                                                                                                           
  Spt5                                                        multiple sites           Increased binding to transcription regulators                    Transcription                                                   N/A                         [@B65]
  Brd4                                                        T204                     Increased stability and transcriptional activity                 Transcription and cancer                                        Yes                         [@B52]
  **mRNA decay factors**                                                                                                                                                                                                                            
  SLBP                                                        T171                     Increased dephosphorylation                                      Cell cycle                                                      Yes                         [@B61]
  AUF1                                                        S83                      Decreased AUF1-mRNA interactions                                 Eosinophil survival, T cell activation, allergic inflammation   Yes                         [@B125]; [@B28]
  KSRP                                                        S181                     Increased dephosphorylation and mRNA interaction                 Hyperparathyroidism                                             N/A                         [@B99]
  HuR                                                         N/A                      mRNA binding affinity                                            Transcription                                                   N/A                         [@B62]

Pin1 and DNA Binding Transcription Factors {#S2}
==========================================

Eukaryotic gene expression is regulated by genomic enhancers and promoters that are recognized by various tissues specific DNA binding transcription factors ([@B103]). Pin1 regulates the activities of a spectrum of transcription factors, many of which are involved in cancer cell proliferation and inflammatory response ([@B78]).

Nucleocytoplasmic Shuttling of Transcription Factors {#S2.SS1}
----------------------------------------------------

A key regulatory step in transcription is the nucleocytoplasmic shuttling of transcription factors, which are synthesized in the cytoplasm and need to be transported into the nucleus, where they bind to the promoters or enhancers to activate gene expression in response to different intra- or extracellular stimuli ([@B15]). A number of studies have shown that Pin1 regulates the nucleocytoplasmic shuttling of transcription factors for the activation or inactivation of transcriptional response. For example, Pin1 promotes nuclear localization of RelA subunit of NF-κB ([@B119]) and β-catenin ([@B118]). Upon cytokine stimulation, Pin1 binds to the phosphorylated Thr254-Pro motif in RelA and increases the nuclear accumulation of RelA by inhibiting its binding to IκBα ([@B119]). IκBα, the inhibitor of NF-κB, is known to sequester NF-κB in the cytoplasm by masking the nuclear localization signal (NLS) of NF-κB ([@B20]). Thr254 of RelA is in the proximity of Ser238, Asp243, and Arg253, three key amino acids involved in the IκBα binding ([@B55]). Phosphorylation of Thr254 and the subsequent of binding of Pin1 likely change the conformation of RelA, therefore preventing its interaction with IκBα□ ([@B119]). NF-κB is a master regulator of inflammatory response and is also a key player in the cancer cell development ([@B20]). By regulating the activation of NF-κB, Pin1 promotes tumor progression and inflammatory cytokine production ([@B119]; [@B3]; [@B32]; [@B130]).

The nucleocytoplasmic shuttling of β-catenin is regulated by its association with APC (the adenomatous polyposis coli), which contains two active nuclear export sequences (NES) for the nuclear export of β-catenin ([@B48]). Pin1 recognizes phosphorylated Ser246-Pro motif of β-catenin. Interestingly, the Ser246-Pro motif is next to the APC binding site ([@B118]). Therefore, Pin1-mediated isomerization of the pSer246-Pro peptide bond in β-catenin would affect its binding to APC, leading to the accumulation of β-catenin in the nucleus and the up-regulation of its target genes, such as cyclin D1 and c-Myc ([@B118]). Since aberrant accumulation of β-catenin contributes to abnormal development and tumorigenesis, Pin1 regulates many processes in development and tumor formation, including osteoblast and neuronal differentiation, cancer cell proliferation, and drug resistance, via affecting the transcriptional activity of β-catenin ([@B118]; [@B92]; [@B129]; [@B142]).

In addition to stimulating the nuclear accumulation of NF-κB and β-catenin, Pin1 can also sequester transcription factors in the cytoplasm to inactivate the target gene expression. The nuclear localization and the transcriptional activity of FOXO4, a tumor suppressor preventing the accumulation of cellular damage due to oxidative stress, are regulated by its monoubiquitination ([@B138]). In response to oxidative stress, Pin1 binds to phosphorylated FOXO4 and increases USP7-mediated FOXO4 deubiquitination, resulting in the decreased monoubiquitination and the increased cytoplasmic accumulation. Ultimately, binding of Pin1 to FOXO4 decreases its transcriptional activity toward its target genes, including the cell cycle arrest gene *p27kip1* ([@B12]).

Another example for the Pin1-mediated nucleocytoplasmic shuttling of transcription factor is nuclear factor activated T cell (NFAT), which is essential for T cell activation ([@B76]). Upon T cell activation, intracellular calcium is increased and NFAT is subject to dephosphorylation by the calcium- and calmodulin (CaM)-dependent protein phosphatase calcineurin, triggering the translocation of NFAT into the nucleus where it binds to the promoter region of a number of cytokines and activates their transcription ([@B164]). Pin1 has been reported to form a stable complex with the phosphorylated form of NFAT, which contains 3 Pin1 binding motifs ([@B76]). Therefore, by controlling the nucleocytoplasmic shuttling, Pin1 functions as a negative regulator of NFAT and T cell activation.

Stability of Transcription Factors {#S2.SS2}
----------------------------------

Another major mechanism of Pin1-mediated transcription factor regulation is through ubiquitin-mediated protein degradation ([@B75]; [@B25]; [@B46]). Pin1 can either increase or decrease the stability of transcription factors, depending on the functionality of these transcription factors.

The tumor suppressor p53 is a key transcription factor regulating cellular pathways such as DNA repair, cell cycle, apoptosis and senescence and is a pivotal gatekeeper against cancer onset and progression ([@B165]). A key regulatory mechanism for the transactivation of p53 is the E3 ligase MDM2-mediated ubiquitination and degradation ([@B165]; [@B90]). In response to DNA damage, p53 is stabilized by its release from MDM2 and activates its downstream target genes to induce cell cycle arrest or cell death ([@B165]). DNA damage induces the phosphorylation of p53 at several Ser/Thr-Pro residues, including Ser33, Ser46, Thr81 and Ser315 ([@B146]; [@B157]; [@B162]). Binding to Pin1 to phosphorylated p53 and the subsequent Pin1-mediated isomerization of p53 prevent the interaction of p53 with MDM2 since binding of Pin1 to pThr81-Pro motif of p53 disassociates p53 from MDM2, leading to stabilized p53 and the activation of p53 target genes ([@B157]).

The stability of p63 and p73, two other p53 gene family members, is also regulated by Pin1 ([@B84]; [@B70]; [@B114]). The conformation of p73 is altered by Pin1-mediated isomerization, promoting its interaction with p300 and the subsequent acetylation in a c-Abl dependent manner, likely preventing the ubiquitination of p73 on the acetylated lysine ([@B84]). As a result, Pin1 augments p73's ability to induce the expression of proapoptotic genes, including *Bax*, *Pig3*, and *p53AIP1* ([@B84]). On the other hand, Pin1 specifically interacts with Thr538-Pro of p63a and disrupts the interaction between p63a and WWP1, an E3 ligase for p63a, resulting in the enhanced transcriptional activity for the expression of proapoptotic gene *Bax* ([@B70]). It appears that Pin1 represents a common mediator linking proapoptotic cooperative activity of the p53 family members. As a regulator of p53, Pin1 regulates many cellular responses related to cell cycle and cell death, including genotoxic response, apoptosis, and mitochondrial apoptotic function ([@B146]; [@B157]; [@B162]; [@B35]; [@B85]).

Pin1 has been demonstrated to increase the stability of c-Jun via inhibition of its ubiquitination ([@B108]). Pin1 binds to c-Jun that is phosphorylated on Ser63/73-Pro motifs by JNK or Ras ([@B147]). Similar to p53, Pin1-mediated isomerization and the conformation change of c-Jun weakens its binding to the E3 ubiquitin ligase Fbw7, therefore attenuating the degradation of c-Jun ([@B23]). A similar mechanism is also identified for Pin1-mediated stabilization of estrogen receptor a(ERa), a key player in the development of breast cancer. ERa is phosphorylated at Ser118-Pro119 and Pin1 binds to this specific phosphorylated serine and induces the *cis-trans* isomerization of Pro119. Binding of Pin1 to ERa disrupts the ubiquitination of ERa by interfering with its interactions with the E3 ligase, E6AP, which is shown to bind to phosphorylated Ser118 and degrade ERa ([@B112]).

While the above examples confirm a role for Pin1 in the stabilization of transcription factors, Pin1 also promotes the degradation of transcription factors. Phosphorylation of Thr58 of c-Myc is critical for its oncogenic potential, since a mutation at Thr58 is often identified in the amplified *c-myc* genes in Burkitt's lymphoma and Thr58 mutant of c-Myc demonstrates enhanced oncogenic potential with increased protein stability ([@B34]). Phosphorylation of Thr58 is important for the recognition of c-Myc by Pin1 via the WW domain, which might lead to the conformational change of c-Myc, facilitating c-Myc dephosphorylation at Ser62 by PP2A and promoting c-Myc turnover by the ubiquitin-proteasome pathway ([@B154]; [@B33]). Therefore, Pin1 triggers the degradation of c-Myc by facilitating the dephosphorylation of c-Myc by PP2A. The increased protein stability and oncogenic potential of Thr58 mutant in Burkitt's lymphoma might result from the defect in Pin1-medaited dephosphorylation of c-Myc.

Pin1 also reduces the stability of tumor suppressive transcription factors. RUNX3, a tumor suppressor in breast cancer ([@B19]), has been identified as a Pin1 substrate. Pin1 recognizes four phosphorylated Ser/Thr-Pro motifs in RUNX3 via its WW domain and reduces the cellular levels of RUNX3 in an isomerase activity-dependent manner by inducing the ubiquitination and proteasomal degradation of RUNX3 ([@B100]). These four motifs are located immediately C-terminal of the runt domain, a region has been shown to be important for RUNX3 stability. Binding of Pin1 to these phosphorylated motifs and the associated conformational change of RUNX3 might result in the recruitment of RUNX3 E3 ligases ([@B100]). Therefore, Pin1-mediated protein degradation might partially account for the decreased RUNX3 expression, an early event in breast cancer progression ([@B22]). Interestingly, Pin1 also regulates the activity of RUNX2, which is another key member of the Runt family proteins and the master transcription factors for bone formation ([@B73]). Different from RUNX3, binding of Pin1 to phosphorylated RUNX2 stabilizes RUNX2 protein by preventing RUNX2 ubiquitination and degradation ([@B66]; [@B156]). Through modulating the stability and transcriptional activity of RUNX2, Pin1 regulates the osteoblast differentiation and skeletal development ([@B66]; [@B156]).

Other transcription factors regulated by Pin1 at the level of protein stability include RelA ([@B119]), β-catenin ([@B118]), IRF3 ([@B120]), Naong ([@B88]), Oct4 ([@B101]), MEF2C ([@B83]), SP1 ([@B153]), Osterix ([@B67]), ATF1 ([@B53]), TR3 ([@B17]), FoxM1 ([@B63]; [@B142]), Smad3 ([@B93]), RAR ([@B40]), FoxO3 ([@B128]), PPARγ ([@B37]; [@B45]), and HIF-1a ([@B44]) ([Table 1](#T1){ref-type="table"}). The detailed mechanisms for how Pin1 regulates their stability might be different for each factor, it appears that changing the accessibility of E3 ligases to the Pin1 substrates due to Pin1-medaited protein conformational change via isomerization might represent a general mechanism for the regulation of protein stability by Pin1. In this regard, Pin1 prevents the binding of E3 ligase RNF4 to SP1 and SPOP for Naong, respectively ([@B153]; [@B159]). By changing the stability of these transcription factors and their transcriptional activities, Pin1 regulates diverse biological processes, including inflammatory response, cell proliferation, stem cell reprogramming, myogenesis, and bone formation ([Table 1](#T1){ref-type="table"}) ([@B75]).

DNA Binding and Transactivation {#S2.SS3}
-------------------------------

DNA binding domain and transactivation domain (TAD) are two essential protein domains that help define a transcription factor. Pin1 is able to modulate both the DNA binding and transcriptional activity of transcription factors. Pin1 binds to the N-terminal Ser118-Pro motif in the intrinsic activation function 1 (AF1) domain of ERα ([@B110]). Binding of Pin1 and the subsequent Pin1-mediated conformational change via isomerization increases ERα DNA binding activity with a concomitant increase in ERα transcriptional activity in estrogen activated breast cancer cells ([@B111]). Pin1 also promotes the binding of c-Myc to the DNA, independent of the protein stability regulated by Pin1 ([@B33]). This regulation requires Pin1 PPIase activity and the phosphorylation of c-Myc on Ser62-Pro63. While Pin1 stimulates the DNA binding activity of ERa and c-Myc, but the Pin1 binding motifs on ERa or c-Myc are not within the DNA binding domain ([@B33]; [@B111]). How Pin1-mediated isomerization in one region could affect the activity of the DNA binding domain on a different region? One possibility is that the conformation change-mediated recruitment of co-activators (e.g., p300 and GCN5) might alter the accessibility of the chromatin, leading to the enhanced DNA binding of the transcription factors and the enhanced transcription of target genes. In this regard, the AF1 domain of ERa is responsible for the recruitment of SRC1 and CBP ([@B27]). c-Myc's interaction with p300 and the recruitment of p300, GCN5, hSNF5, and pTEFb to promoters is also facilitated by the binding of Pin1 ([@B33]; [@B121]). It has to be noted that Pin1 can also decrease the DNA binding activity of transcription factors. Binding of Pin1 to phosphorylated Thr739 of Sp1 has been reported to cause Sp1 to move out of the chromosome completely by decreasing its DNA binding activity during mitosis ([@B153]).

While changing the DNA binding affinity would affect the transcriptional activity of a transcription factor, Pin1 can also regulate the transcriptional activity by directly binding to the TADs of the transcription factors ([@B86]; [@B79]; [@B139]; [@B81]; [@B106]; [@B91]) ([Table 1](#T1){ref-type="table"}). Phosphorylation of the carboxyl-terminal transactivation domain of c-Fos by extracellular signal-regulated kinases (ERK) in response to growth factors is essential for the transcriptional activation of AP-1, heterodimer of c-Jun and c-Fos ([@B87]). Pin1 binds to c-Fos through specific pSer/Thr-Pro sites within the c-Fos TAD, and this interaction results in an enhanced transcriptional response of c-Fos to polypeptide growth factors that stimulate ERK ([@B86]). The detailed mechanism for this enhanced transactivation is undetermined, but likely results from the change of interactions from transcription related proteins of the TAD ([@B86]).

Pin1 has also been shown to regulate the transcriptional activity of glucocorticoid receptor (GR) by binding to the TAD. Binding of Pin1 to the phosphorylated Ser203 and Ser221 within the TAD of GR enhances the transactivation of GR ([@B106]). Interestingly, this enhanced transactivation appears to result from enhanced recruitment of GR to the promoters of its GR target genes but not directly from the transactivation ([@B106]). How the binding of Pin1 to the TAD enhances the DNA binding activity of GR remains to be determined. It is possible that Pin1-mediated conformational change of TAD would affect the conformation of DNA binding domain, which is adjacent to the TAD ([@B106]).

Pin1 also regulates the transcriptional activity of HIF-1a. Pin1 interacts with p42/p44 MAPK-mediated phosphorylation of HIF-1a at Ser641 and Ser643 of the transactivation region and promotes its conformational changes for the efficient expression of HIF-1a genes, including VEGF, GLUT1 and PGK1 ([@B56]). It has been speculated that the enhanced transactivation of HIF-1a might stem from the increased HIF-1a binding to DNA or transcriptional cofactors ([@B56]).

Pin1 and the Transcription Co-regulators {#S2.SS4}
----------------------------------------

Transcription factors often recruit transcription co-activators for their full transcriptional potential and biological functions ([@B132]). Pin1 regulates the activity of some transcription co-regulators to control the effective gene expression.

Steroid receptor-mediated transcription requires the ligand-dependent association of receptors with steroid receptor coactivator 3 (SRC-3) ([@B82]). Pin1 interacts with phosphorylated SRC-3 and regulates its co-activation function by enhancing its interaction with CBP/p300 and stimulating its cellular turnover, facilitating the cyclic recruitment of nascent phosphorylated SRC-3 to the promoter ([@B155]).

Pin1 also regulates CREB co-activator CRTC2 (CREB-regulated transcriptional co-activator 2) by binding to phosphorylated CRTC2 at Ser136, which locates within its nuclear localization signal ([@B97]). Different from SRC-3, binding of Pin1 to phosphorylated CRTC2 suppresses the co-activation function of CRTC2 by attenuating its nuclear localization and cAMP-responsive element (CRE) transcriptional activity ([@B97]).

A recent study also demonstrates that transcriptional co-activator PRDM16 is negatively regulated by Pin1 ([@B95]). PRDM16 plays crucial roles in the determination and function of brown and beige fat as well as in hematopoiesis and cardiac development ([@B21]). Pin1 interacts with phosphorylated PRDM16 at Ser44A, Ser52A, Thr61A and Ser66A, promotes its degradation and the suppression of the thermogenic response ([@B21]). The detailed mechanism for Pin1-mediated PRDM16 degradation remains undetermined. Nevertheless, by regulating the activity of co-activators such as CRTC2 and PRDM16, Pin1 is involved in the regulatory mechanism governing the glucose metabolism and adipose thermogenesis ([@B96]).

In the Notch1 signaling pathway, activation of CSL \[CBF-1, Su(H), Lag-1\] -target genes requires the co-activation function of the intracellular domain of the notch protein (NICD), which is released from the membrane-bound Notch1 protein processed by the γ-secretase ([@B11]). NICD has also been shown to be a co-activator for Notch-mediated activation of LEF-1 target gene independent of its co-activation function for CSL ([@B116]). Binding of Pin1 to Notch1 stimulates the processing of the Notch1 from its inactive transmembrane form to γ-secretase-processed, activated nuclear localized form ([@B117]). The catalytic activity of Pin1 is required for the cleavage of the Notch protein by γ-secretase for the release of NICD ([@B117]). By mediating the generation of NICD, Pin1 regulates gene expression in Notch signaling pathway.

In addition to the regulation of transcription co-activators, Pin1 can control gene expression by targeting transcription co-repressors. Silencing mediator for retinoic acid and thyroid hormone receptor (SMRT) is a transcriptional corepressor that participates in diverse signaling pathways and human diseases ([@B18]). Pin1 interacts with SMRT and regulates SMRT protein stability, thereby affecting SMRT-dependent transcriptional repression ([@B136]). SMRT is phosphorylated by Cdk2 at Ser1241, Ser1445 and Ser1469. Cdk2-mediated phosphorylation of SMRT at these serines is required for Pin1 binding and the decreased SMRT stability. More importantly, ErbB2 destabilizes SMRT protein level via Cdk2-Pin1 axis, suggesting that ErbB2 signaling upstream of Cdk2 and Pin1 is a potential regulatory cascade involved in regulating the stability of SMRT ([@B136]). Interestingly, two of the Cdk2 phosphorylation sites of the Pin1 binding motifs in SMRT are conserved in N-CoR, a closely related transcription repressor ([@B135]), suggesting that the activity of N-CoR might be regulated by Pin1 via a similar mechanism.

Pin1 and RNA Polymerase II {#S3}
==========================

Transcription factors and transcription coactivators are essential for the recruitment of RNAPII to the promoters or enhancers to activate transcription. The C-terminal domain (CTD) of Rpb1, the largest subunit of RNAPII, which consists of 26-52 tandem heptapeptide repeats with the general consensus sequence Tyr~1~-Ser~2~-Pro~3~-Thr~4~-Ser~5~-Pro~6~-Ser~7~ from yeast to human. The proline-rich CTD functions as a docking platform for numerous transcription regulatory proteins involved in transcription initiation, elongation, termination and post-transcription processing ([@B42]). The CTD is marked by a number of post-translational modifications, including phosphorylation, glycosylation, methylation, and acetylation ([@B13]). During the early events of transcription initiation, unphosphorylated RNAPII, general transcription factors and a mediator complex are recruited onto the promoters to form the pre-initiation complex (PIC) ([@B137]). Phosphorylation of Ser5 promotes the dissociation of RNAPII from PIC and the promoter clearance, processes that are required for transition from initiation to early elongation ([@B105]; [@B131]). Different from phosphorylated Ser5, phosphorylation of Ser2 results in the recruitment of elongation, termination and 3′ end processing factors, allowing the coupling of transcription elongation with mRNA processing ([@B9]; [@B1]).

Pin1 binds to both pSer2-Pro3 and pSer5-Pro6 of the CTD ([@B149]; [@B160]). Pin1's binding to CTD depends on the phosphorylation of Ser2 by kinases CDK2 and CDK9 ([@B59]; [@B5]), and the phosphorylation of Ser5 by CDK7 ([@B105]). Pin1 induces the conformational changes of the CTD, leading to the recruitment of CTD-modifying enzymes and transcription regulatory proteins essential for RNAPII function ([@B46]). The presence of two Ser-Pro motifs with the CTD repeats creates four possible *cis*-*trans* configurations, and thus expands the complexity of the CTD code signature by providing a scaffold for the recruitment of a variety of chromatin and RNA processing factors ([@B134]). The *cis* or *trans* configuration of the Pin1 binding motifs on CTD determines the transcription outcome via the recruited factors. For example, Mce (capping enzyme), Pcf11 (3′ end processing factor), Scp1 (CTD phosphatases) and SCAF8 (splicing factor) bind to phosphorylated CTD with the prolines in *trans* configuration ([@B30]; [@B102]; [@B161]; [@B7]; [@B39]). In contrast, Ssu72 and the termination factor Nrd1 bind CTD with phosphorylated Ser5-pro6 in the *cis* configuration ([@B148]; [@B144]; [@B64]).

RNAPII is subject to regulatory control at all steps of transcription cycle, including initiation, elongation and termination. The high selectivity of transcription regulatory proteins for *cis* or *trans* isomers supports the idea that Pin1 serves as a key transcription regulator for gene expression. However, how Pin1 creates and maintains the *cis* or *trans* configuration of CTD in during transcription cycle remains obscure and merit further investigation.

Pin1 and Transcription Initiation {#S4}
=================================

Transcription initiation encompasses multiple steps, including the exposure of promoters in chromatin, the association of promoters with RNAPII and transcription regulatory proteins to form PIC, and the clearance of promoter for the release of RNAPII ([@B69]). The wrapping of promoter DNA around a histone octamer in the nucleosome suppresses transcription initiation. The ordered disassembly of nucleosomes facilitates transcription by allowing RNAPII to interact with the promoters. Histone H1 plays a crucial role in maintaining higher order chromatin structure and reversible phosphorylation of H1 is closely correlated with transcription initiation with increased phosphorylation of H1 associating with a relaxed chromatin structure, allowing the access of RNAPII and DNA-binding proteins to the promoter region ([@B50]; [@B140]).

Pin1 has been demonstrated to bind to H1 via phosphorylated S/T-Pro residues on the C-terminal of H1 ([@B109]). Pin1 promotes dephosphorylation of H1 and stabilizes H1's interaction with chromatin to facilitate condensation, implying that Pin1 may act as a suppressor of transcription initiation. The idea that Pin1 inhibits transcription initiation is supported by *in vitro* transcription assays demonstrating that Pin1 inhibits transcription initiation in nuclear extracts whereas an inactive Pin1 mutant stimulates transcription initiation ([@B150]). Pin1 might also inhibit transcription initiation via dephosphorylation of Ser5 of the CTD of RNAPII ([@B144]). However, some studies indicate that Pin1 might have a positive effect on transcription initiation since Pin1 inhibitor Juglone disrupts the formation of functional PIC ([@B16]). The discrepancy in these studies might result from the different *in vitro* and *in vivo* assays and the approaches to inhibit Pin1. For example, Pin1 inhibitor Juglone is known to be toxic to the cells and might have off-target effects, which accounts for the initiation inhibition ([@B94]). Pin1 has also been shown to regulate the chromosome condensation during mitosis targeting the topoisomerase (Topo) IIa ([@B150]).

While Pin1 indirectly regulates the transcription initiation by affecting the chromosome structure, it is also possible that Pin1 might directly affect the activity of transcription initiation factors. The activity of transcription initiation factor TFIID is tightly regulated by phosphorylation. During mitosis, TFIID is phosphorylated at multiple sites and phosphorylated TFIID is unable to direct activator-dependent transcription ([@B123]). Considering that Pin1 is a major regulator of mitosis ([@B75]), Pin1 might target TFIID to regulate transcription during cell cycle. Interestingly, mice deficient in TAF4b, a gonad-specific subunit of TAFIID exhibit germ cell deficiency, a phenotype similar to Pin1^--/--^ mice ([@B31]). These studies provide genetic evidence linking Pin1 to TFIID, but the detailed mechanism how Pin1 regulates TFIID for the transcription initiation needs to be further investigated.

Pin1 and Transcription Elongation {#S5}
=================================

After ∼20--60 bp RNA is synthesized, RNAPII is repressed by negative elongation factors, such as DSIF (DRB sensitivity-inducing factor) and NELF (negative elongation factor) at promoter-proximal pausing sites ([@B141]; [@B152]). CDK9, a catalytic subunit of P-TEFb (positive transcriptional elongation factor b), is recruited and activated by Brd4 (Bromodomain-containing protein 4), and phosphorylates NELF, DSIF and Ser2 in the CTD of RNAPII ([@B72]). Phosphorylation of NELF and DSIF by CDK9 removes these negative factors from the pausing sites, releasing the paused RNAPII into the productive elongation phase ([@B38]). Pin1 seems to play a role in the transcription elongation by removing the negative elongation factor DSIF and activating the positive elongation factor P-TEFb.

Pin1 binds to the hSpt5 subunit of DSIF via its phosphorylated carboxyl terminal part 2 (CTR2) domain by Cdk9 ([@B65]). The CTR2 domain contains a p(T/S)PSP(Q/A)(S/G)Y motif, which resembles the CTD repeats of RNAPII ([@B46]). hSpt5 is phosphorylated by CDK9 in interphase but not in mitosis and this interphase form of phosphorylated hSpt5 is bound to the nuclear matrix, indicating its involvement in transcription ([@B65]). Binding of Pin1 to phosphorylated hSpt5 induces the conformational change of hSpt5 via isomerization, leading to the subsequent change of its phosphorylation status and the conversion of DSIF from a repressor to an activator ([@B65]).

In mammalian cells, Brd4 regulates transcription elongation by recruiting P-TEFb to stimulate the phosphorylation of the CTD of RNAPII ([@B57]; [@B2]). Brd4 has emerged as an important factor in tumorigenesis by promoting the transcription of genes involved in cancer development ([@B89]; [@B145]; [@B6]; [@B58]). Our recent studies demonstrate that the stability and functions of Brd4 are positively regulated by Pin1 in cancer cells ([@B52]). Pin1 directly binds to phosphorylated Thr204 of Brd4 by an unidentified kinase and enhances Brd4's stability by inhibiting its ubiquitination. Pin1 also catalyzes the isomerization of Pro205 of Brd4 and induces its conformational change through a *cis-trans* isomerization, which leads to enhanced CDK9 binding to Brd4 and enhanced recruitment of CDK9 to a subset of promoters of Brd4-mediated tumor-promoting genes, including c*-MET* and *MMP9* ([@B52]). In addition to the enhanced CDK9 binding, Pin1-mediated conformational change might also decrease the accessibility of a Brd4 E3 ligase or increase the accessibility of a Brd4 deubiquitinating enzyme for the increased protein stability with reduced ubiquitination ([@B52]). Therefore, the overall tumor-promoting activity of Brd4 in cancer cells might result from the Pin1-mediated conformational change of Brd4, leading to more stabilized Brd4 and conformational change-associated transcriptional potential increase ([@B52]).

Pin1 and Transcription Termination {#S6}
==================================

Termination of transcription involves the release of RNA transcripts, the dissociation of RNAPII and its binding proteins from the DNA, coupled with the cleavage of 3′ end of the nascent transcript and the polyadenylation ([@B115]). Phosphorylation of RNAPII at Ser2 or Ser5 is closely related to transcription termination. Levels of Ser5 phosphorylation is high near the transcription start site, while Ser2 phosphorylation increases over the gene body, peaking near the transcription termination site ([@B51]). Pin1 increases the dephosphorylation of Ser5, but not Ser2, by CTD phosphatase Ssu72 ([@B60]; [@B144]). Pin1 also inhibits the CTD dephosphorylation by affecting the activity of another CTD phosphatase, Fcp1, or increasing the CTD phosphorylation by Cdc2/Cyclin B ([@B150], [@B151]). As such, Pin1 can regulate the transcription termination by changing the phosphorylation status of CTD of RNAPII.

Various phosphorylation status of CTD of RNAPII creates a CTD code that dictates the assembly and disassembly of factors to the RNAPII and determines the transcription outcome. Pin1 has been implicated in the construction and deciphering the CTD code ([@B14]). In yeast, mRNA 3′-end processing factor Pcf11 binds to CTD repeats of RNAPII containing Pro3 in the *trans*-configuration ([@B102]), whereas the termination factor Nrd1 binds to the *cis* form of phosphorylated Ser5 ([@B64]). By changing the *cis-* or *trans*-configuration of prolines in CTD and coordinating the recruitment of the termination and/or 3′ -end mRNA processing factors, such as Pcf11, Rtt103 and Nrd1 ([@B102]; [@B80]; [@B64]), Ess1 (yeast Pin1) might facilitate the transcription termination. A similar regulator mechanism might also occur in mammalian cells since these CTD binding factors are highly conserved in eukaryotic cells.

Pin1 and the Post-Transcriptional Regulation of Gene Expression {#S7}
===============================================================

mRNA levels are determined by a complex interplay between the rates of gene transcription and mRNA decay ([@B122]). mRNA decay is closely associated with the 3′ untranslated region (3′-UTR) of the mRNAs. Many early response genes contain AU-rich element (ARE) in 3′-UTRs ([@B4]). AREs occur in up to 5--8% of all mRNA transcripts in human cells and these AREs are recognized by AU-binding proteins (AUBPs), which promote either decay or stabilization of mRNA on a gene- and cell type-specific manner ([@B4]; [@B43]). Many AUBPs are phosphoproteins and their activity is tightly regulated through reversible phosphorylation ([@B127]). Via binding to the specific phosphorylated AUBPs, Pin1 controls mRNA decay of selective genes.

Histone mRNAs are rapidly degraded at the end of S phase, and a 26-nucleotide stem-loop in the 3′-UTR is a key determinant of histone mRNA stability ([@B47]). This sequence is the binding site for stem-loop binding protein (SLBP), which helps to recruit components of the RNA degradation machinery to the histone mRNA ([@B143]). Pin1 binds to phosphorylated Thr171-Pro172 of SLBP and promotes its dephosphorylation by PP2A, causing its dissociation from histone mRNA hairpin, triggering the rapid degradation of histone mRNA ([@B61]). Another example for Pin1-mediated mRNA stability is the mRNA of the parathyroid hormone (PTH), which regulates the serum calcium via its effect on bone, kidney, and intestine ([@B99]). The stability of *PTH* mRNA is decreased by the binding of K-homology splicing regulator protein (KSRP) to a *cis*-acting element in the 3′-UTR region of *PTH* mRNA ([@B98]). Pin1 interacts with the phosphorylated Ser181 of KSRP and induces the *cis-trans* isomerization of the proline bond in KSRP. The conformational change of KSRP exposes the phosphorylated Ser181, triggering the dephosphorylation, an event that is required for the activation of KSRP. Activated KSRP then interacts with *PTH* mRNA and induces its decay ([@B99]).

Pin1 can also regulate the mRNA stability of cytokine via binding to AUBPs. AUF1 typically functions as a destabilizing protein for AU-rich mRNAs, including *GM-CSF* and *c-Fos* ([@B77]). Pin1 associates with phosphorylated AUF1 and disassociates AUF1 from the mRNA of *GM-CSF* in activated eosinophils and T cells ([@B125]; [@B28]). Binding of Pin1 to AUF1 changes the conformation of AUF1 and attenuates its RNA binding activity, leading to the stabilization of *GM-CSF* mRNA by HuR or hnRNP C ([@B125]; [@B28]). Via a similar mechanism, Pin1 regulates the stability of *TGF-β1* mRNA and *c-Fos* mRNA ([@B126]; [@B62]). Regulation of mRNA stability by targeting specific RNA binding proteins, including AUF1, KSRP, SLBP, and HuR, might represent another layer of gene regulation by Pin in cancer and inflammatory response.

MicroRNAs (miRNAs) are small, endogenous non-coding RNAs of 18--24 nucleotides in length and play significant roles in the regulation of gene expression and participate in numerous cellular processes, including cell cycle arrest, cell proliferation and death ([@B8]). miRNAs bind to the 3′-UTR of target mRNAs via nucleotide pairing and regulates the target gene expression by decreasing the mRNA stability or translation ([@B29]). The biogenesis of miRNAs is tightly controlled at multiple steps, including RNAPII-dependent transcription of miRNA genes, Drosha- and Dicer-mediated processing of primary miRNAs (pri-miRNAs) or precursor miRNAs (pre-miRNA), and the nuclear export of (pre-miRNAs) to the cytoplasm by exportin-5 (XPO5) ([@B41]). Recent studies demonstrate that the biogenesis of miRNAs, especially the XPO5-mediated export of pre-miRNA, is regulated by Pin1 ([@B71]; [@B107]). Pin1 binds to the ERK-mediated phosphorylated XPO5 in hepatocellular carcinoma (HCC) and changes XPO5's conformation through *cis-trans* isomerization, leading to the retention of XPO5 in the nucleus and the impaired nuclear export of pre-miRNAs ([@B71]). As a result, several tumor suppressor miRNAs, including miR-200b, miR-146a and miR-122, are down-regulated in HCC ([@B71]). Down-regulation of these miRNAs likely changes the expression of their target genes, promoting the development of HCC ([@B71]; [@B107]). Therefore, Pin1 is also able to regulate gene expression at the post-transcriptional level via controlling the biogenesis of miRNAs, adding another regulatory layer for mRNA stability.

Summary and Perspectives {#S8}
========================

Pin1 is involved in almost every step of gene expression, from activation of transcription factors to transcription initiation and termination by targeting a host of transcription factors and transcription regulatory proteins ([Table 1](#T1){ref-type="table"}). In many cases, Pin1 binds to the phosphorylated transcription factors and induces the protein conformational change via isomerization, although direct evidence for the isomerization-mediated conformational change is missing in some of the studies ([Table 1](#T1){ref-type="table"}). Conformation change accounts for the changes of various protein properties, including protein stability, subcellular localization, phosphorylation status, protein-protein interactions, protein-DNA interactions, leading to the increased or decreased transcriptional potential of these transcription factors ([Figure 1](#F1){ref-type="fig"}). In addition, Pin1 also targets RNA polymerase II through interacting with the CTD of Rbp1. Pin1-mediated isomerization of prolines or phosphorylation status of CTD generates a CTD code for recruitment or disengagement of transcription regulatory proteins required for transcription initiation, elongation and termination ([Figure 2](#F2){ref-type="fig"}). Finally, Pin1 controls mRNA decay by interacting with AUBPs ([Figure 2](#F2){ref-type="fig"}). It has to be noted that Pin1 often affects the activity of a single substrate via multiple mechanisms. For example, Pin1 regulates the nucleocytoplasmic shuttling and the stability of RelA and β-catenin ([@B118], [@B119]). Pin1 also regulates both the stability and DNA binding activity ERa ([@B112], [@B111]). Via these multi-level regulations, Pin1 might impose the spatiotemporal control of the expression of a subset of genes.

![Pin1 regulates the activation of transcription factors via distinct mechanisms: ① affects nucleocytoplasmic shuttling; ② affects protein stability by ubiquitination; ③ affects DNA-binding affinity; ④ affects protein interaction; ⑤ regulates phosphorylation or dephosphorylation.](fcell-08-00179-g001){#F1}

![Pin1 regulates gene expression network. During transcription initiation, Pin1 promotes dephosphorylation of Histone H1 and Ser5 in the CTD of RNA polymerase II, to inhibit the recruitment of TRP (transcription regulatory proteins) and pre-initiation complex, and promoter clearance, processes that are required to transcription initiation. During transcription elongation, on one hand, Pin1 binds to phosphorylated Spt5 and might facilitate conversion of DSIF from a negative elongation factor into a positive elongation factor. On the other hand, Pin1 enhances Brd4's stability and its interacting with CDK9 to phosphorylate Ser2 in the CTD of RNA polymerase II, and thus increases transcription elongation. In transcription termination, Pin1 binds to phosphorylated Ser2 in the CTD of RNAPII and facilitates coordinate recruitment of TTF (transcription termination factors). After the synthesis of mRNA, Pin1 binds to AUBPs (AU-binding proteins) to accelerate or slow mRNA decay.](fcell-08-00179-g002){#F2}

Epigenetics plays crucial roles in the regulation of gene expression by post-translational modifications of histone proteins and methylation of DNA ([@B24]). Epigenetic regulation is mediated by various enzymes that add or remove various modifications (writers and erasers) and the proteins that recognize these modifications (readers) ([@B24]). While some PPIases regulating histone modifying enzymes have been reported ([@B46]), studies on epigenetic regulation of gene expression by Pin1 are largely missing. We have recently shown that epigenetic reader Brd4, which specifically binds to the acetylated lysine on histone and non-histone proteins, is a Pin1 substrate and the stability and transcriptional activity of Brd4 is regulated by Pin1-catalyzed isomerization ([@B52]). Whether and how Pin1 regulates gene expression via targeting these epigenetic regulators remain exciting questions and need to be further investigated. Many of these epigenetic factors are dysregulated in cancer and the highly expressed Pin1 in cancer might contribute to the dysregulation.

Pin1-catalyzed isomerization and the subsequent protein conformational change might accounts for all the functional changes of Pin1 substrates. Protein conformational change often leads to the engagement or disassociation of the interacting proteins. The alteration of protein stability after conformational change is largely affected by the changes in the accessibility to E3 ligases. Conformational change can also alter the accessibility of the NLS or NES to the nuclear import or export machinery, affecting the nucleocytoplasmic shuttling of the transcription factors. However, how Pin1 directly regulates the DNA binding activity via protein conformational change is not quite clear. Although it is generally believed that binding of Pin1 leads to the conformational changes of its substrates, many studies failed to include the isomerase inactive mutant of Pin1 ([Table 1](#T1){ref-type="table"}), an issues needs to be addressed in the future studies.

Pin1 could have completely opposite effects on its substrates. Pin1 increases or decreases the stability of transcription factors in a similar phosphorylation and isomerization-dependent manner ([Table 1](#T1){ref-type="table"}). Pin1 regulates the activities of a spectrum of transcription factors, many of which are oncogenes and tumor suppressors ([@B78]). Pin1 is aberrantly activated in most cancers and Pin1 generally activates the oncogenic transcription factors but inhibits the tumor suppressive transcription factors, reflecting Pin1's ability to promote cancer cells by activating caner promoting factors and inactivating cancer suppressive factors ([@B163]). However, it is not clear how Pin1 imposes the opposite regulatory effects on oncogenic and tumor suppressive transcription factors. One possibility is that the expression of the target genes of these transcription factors and the resulting cellular functions might provide some feedback signals for Pin1 to determine the fates of these transcription factors.

While Pin1 is able to regulate gene expression at various levels, it is possible that Pin1 is not absolutely required for the transcription of whole genome. The success rate of Pin1^--/--^ homozygous cross breeding was much lower that that of heterozygous mice, indicating a critical role of Pin1 in gene expression and cell division ([@B74]). Consistently, Pin1^--/--^ fibroblasts grow normally but with defect in re-entering the cell cycle from G~0~ arrest ([@B36]; [@B74]). Pin1-mediated transcription and gene expression is clearly a cell type-specific and signal-dependent event since many transcription factors and their target genes are inducible in response to specific stimuli. Studies on the transcription regulation by Pin1 were largely performed *in vitro* or in cultured cells with recombinant or overexpressed Pin1. The significance of these biochemical studies in gene regulation would be strengthened if similar regulatory mechanism would be confirmed in Pin1^--/--^ or Pin1 conditional knockout mice in combination with mouse disease models. A great example is demonstrated in a recent study of the identification of Pin1 as a regulator of thermogenesis by targeting PRDM16 for degradation ([@B95]).

While a great deal is known about how Pin1 regulates the activation transcription factors for gene expression in response to stimuli, much less is known about how Pin1 regulates the transcription machinery for the spatiotemporal control of gene expression except that Pin1 helps to construct the CTD code. It also remains to be determined whether these regulations on RNAPII and the associated transcription is a general mechanism that can apply to all genes or whether it is only a gene-specific and cell-specific phenomenon. Furthermore, the subcellular localization, the expression levels and the activity of Pin1 are subject to change in response to stimulation and in diseases conditions ([@B10]; [@B68]; [@B113]; [@B158]), adding another layer of complexity to Pin1-mediated gene expression. Overall, better understating the regulation of gene expression by Pin1 would provide new insights into the pathophysiological functions of Pin1 and new therapeutic approaches for the treatment of cancer and other human diseases by targeting Pin1 alone or in combination with targeting different transcription regulators.
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